[Research on the antimetastatic agents].
Takeshima
Hideo
H
Department of Neurosurgery, Kagoshima University Hospital.
D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors; D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000081247:CSK Tyrosine-Protein Kinase; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors; D002465:Cell Movement / Q000187:drug effects; D016207:Cytokines / Q000502:physiology / Q000627:therapeutic use; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology / Q000627:therapeutic use; D061965:Matrix Metalloproteinase Inhibitors; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control*; D009360:Neoplastic Cells, Circulating; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D009570:Nitriles / Q000494:pharmacology / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects; D019061:src-Family Kinases
D043925:Angiogenesis Inducing Agents; D000814:Aniline Compounds; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D015815:Cell Adhesion Molecules; D016207:Cytokines; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D061965:Matrix Metalloproteinase Inhibitors; D009570:Nitriles; D010975:Platelet Aggregation Inhibitors; D011804:Quinolines; C013065:cell aggregation factors; C112567:etaracizumab; C471992:bosutinib; C100342:marimastat; D011505:Protein-Tyrosine Kinases; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases; C000631346:CSK protein, human